Clinical Trials Logo

Filter by:
NCT ID: NCT05388045 Enrolling by invitation - Clinical trials for Substance Use Disorders

Piloting a Patient-Reported Outcome Measure for Opioid Use Disorder Recovery in a Clinical Setting

RecoveryPROM
Start date: April 14, 2022
Phase: N/A
Study type: Interventional

Performance measure can improve quality of care at the patient, provider, and systems level of care, and patient-reported outcome measures bring a needed patient-centered focus. Recovery has been difficult to measure for people with substance use disorders, and is more challenging in the context of opioid use disorders (OUD) and treatment medications. This study will examine a recovery patient-reported outcome measure to determine if patients and clinicians find it useful and acceptable in the clinical context, and if it leads to improved outcomes.

NCT ID: NCT06034106 Enrolling by invitation - Clinical trials for Pomegranate (P. Granatum) Peel Compress

The Effect of Pomegranate (Punica Granatum L.) Peel Compress Application on Pain and Physical Function Status

Pomegranate
Start date: April 14, 2023
Phase: N/A
Study type: Interventional

Osteoarthritis is the most common type of arthritis among rheumatologic diseases. Complementary therapies are one of the effective methods for pain control. This study was planned as a randomized controlled experimental study. For this purpose, patients diagnosed with knee osteoarthritis who applied to the Orthopedics Outpatient Clinic will be included. It was calculated that the study would include at least 67 patients. The study will be collected using patient information form, descriptive characteristics form, Visual Analog Scale (VAS) and WOMAC osteoarthritis application scale. It was planned as a randomized controlled experimental study to evaluate the effect of pomegranate peel (P. granatum) compress application on pain and function status. The study was divided into 3 groups as Pomegranate (Punica granatum) peel compress, hot compress and control group. Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.

NCT ID: NCT06386653 Enrolling by invitation - Lung Cancer Clinical Trials

Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1

Start date: April 14, 2024
Phase: Phase 1
Study type: Interventional

The study should evaluate the biological distribution of [123I]I-DARPIN-Ec1 in patients with lung and ovarian cancer The primary objective are: 1. To assess the distribution of [123I]I-DARPIN-Ec1 in normal tissues and tumors at different time intervals. 2. To evaluate dosimetry of [123I]I-DARPIN-Ec1. 3. To study the safety and tolerability of the drug [123I]I-DARPIN-Ec1 after a single injection in a diagnostic dosage. The secondary objective are: 1. To compare the obtained [123I]I-DARPIN-Ec1 SPECT imaging results with the data of CT and/or MRI and/or ultrasound examination and immunohistochemical (IHC) studies in lung and ovarian cancer patients.

NCT ID: NCT03807934 Enrolling by invitation - Cognitive Change Clinical Trials

Cerebral Excitability and Cognitive Performance

Start date: April 15, 2013
Phase: N/A
Study type: Interventional

This study investigates the perceptual and cognitive influences of low-intensity electrical brain stimulation (transcranial direct current stimulation; tDCS), versus control (sham) conditions.

NCT ID: NCT03128450 Enrolling by invitation - Parkinson Disease Clinical Trials

A Study To Evaluate the Safety and Efficacy of Human Neural Stem Cells for Parkinson's Disease Patient

hNSCPD
Start date: April 15, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This Pilot study will evaluate the safety and Efficacy of an investigational cell transplantation therapy, h-NSC, in patients with Parkinson's disease, through nasal drug delivery, a new delivery way. All patients will receive the therapy, which consists of human neural stem cells,

NCT ID: NCT03343444 Enrolling by invitation - Clinical trials for Hepatitis C Virus Infection, Response to Therapy of

Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents

Start date: April 15, 2017
Phase: Phase 3
Study type: Interventional

Randomized, open-label study in treatment naïve and treatment experienced, adolescence to determine the efficacy of Sofosbuvir 400mg/ledipasvir 90mg in treatment naïve and treatment-experienced adolescence. Hepatitis C virus (HCV) infection as measured by the proportion of subjects with sustained viral response 12 weeks after discontinuation of therapy (SVR12)

NCT ID: NCT03456089 Enrolling by invitation - Clinical trials for Urinary Bladder, Neurogenic

Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing

Start date: April 15, 2018
Phase: N/A
Study type: Interventional

The investigators have developed a novel pressure monitoring device that hooks to standard urinary catheters. The investigators will be testing how the pressure measurements recorded with this device compare to the gold standard measurement of urodynamics.

NCT ID: NCT03584633 Enrolling by invitation - Lymphedema Clinical Trials

Effect of Exercise on Indocyanine Green (ICG) Lymphography Imaging

Start date: April 15, 2019
Phase: Phase 4
Study type: Interventional

Indocyanine Green (ICG) lymphography is a relatively new imaging technique that allows for quick visualization of superficial lymph flow in real-time, without radiation exposure. This imaging is useful for diagnosing and assessing lymphedema. ICG lymphography has a higher sensitivity and specificity than lymphoscintigraphy, the current gold standard imaging device for lymphedema. ICG lymphography precisely and reliably diagnoses, tracks, and stages lymphedema severity, ranging from subclinical or early lymphedema to more advanced cases. The ICG contrast dye used to visualize the lymphatic system takes approximately six hours to plateau. Therefore, patients must wait six hours between their initial and delayed scans. The purpose of this study is to determine if exercising on a Nu-step device between ICG initial and delayed scans would shorten the period of time a patient had to spend at the hospital on the day of their ICG lymphography. The general procedures for this involve (after selecting subjects, consenting subjects, educating the subject on the protocol, along with other appropriate measures): - Taking baseline vitals (HR & SpO2) and limb circumference measurements - 5-minute period of time to acquaint subject with the exercise equipment (Nu-Step) at any level of exertion - injection of contrast agent to allow for visualization of the superficial lymphatic system by a qualified nurse - Initial scan - A 5-minute period of exercise at "moderate" level of exercise (This correlates to the rating of perceived exertion levels of 12-13; All exercise periods should be at this level and will be monitored by a provider) - Second scan & vitals - 5-minute period of exercise - Third scan & vitals o Continue 5-minute exercise period followed by scan & vitals until disease pattern emerges * Exercise for 5 minutes then scan and vitals until images reach steady state for two consecutive scans - Final vitals (HR & SpO2) * Repeat scan every 1 hour until the normal 6 hour scan to monitor for further changes in lymphatic pattern. - Exit survey

NCT ID: NCT06187584 Enrolling by invitation - Clinical trials for Supracondylar Humerus Fracture

SCHF Post-Op Study Between Opioid and Non-Opioid Pain Management

Start date: April 15, 2019
Phase: Phase 4
Study type: Interventional

This purpose of this study is to determine the efficacy of nonopioid versus opioid analgesic regimens following surgical fixation of Gartland Type III Supracondylar Humoral Fractures (SCHFs) to assist in the development of a standard outpatient pain management regimen in the treatment of these injuries.

NCT ID: NCT04340089 Enrolling by invitation - Intestinal Diseases Clinical Trials

Squatting on the Toilet and Capsule Endoscopy

SC
Start date: April 15, 2020
Phase:
Study type: Observational

This study evaluates the effect of squatting on the toilet on gastric transit time and complete examination rate of capsule endoscopy.In the observation group, the patients could go to squatting on the toilet at any time as they want to after taking the capsule.